Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 175

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma

Open access
Hervey-Jumper, Shawn L., Zhang, Yalan, Phillips, Joanna J., Morshed, Ramin A., Young, Jacob S., McCoy, Lucie, Lafontaine, Marisa, Luks, Tracy, Ammanuel, Simon, Kakaizada, Sofia, Egladyous, Andrew, Gogos, Andrew, Villanueva-Meyer, Javier, Shai, Anny, Warrier, Gayathri, Rice, Terri, Crane, Jason, Wrensch, Margaret, Wiencke, John K., Daras, Mariza, Oberheim Bush, Nancy Ann, Taylor, Jennie W., Butowski, Nicholas, Clarke, Jennifer, Chang, Susan, Chang, Edward, Aghi, Manish, Theodosopoulos, Philip, McDermott, Michael, Jakola, Asgeir S., Kavouridis, Vasileios K., Nawabi, Noah, Solheim, Ole, Smith, Timothy, Berger, Mitchel S., Molinaro, Annette M. · 2023 · Journal of Clinical Oncology

Abstract

PURPOSE: In patients with diffuse low-grade glioma (LGG), the extent of surgical tumor resection (EOR) has a controversial role, in part because a randomized clinical trial with different levels of EOR is not feasible. METHODS: In a 20-year retrospective cohort of 392 patients with IDH-mutant grade 2 glioma, we analyzed the combined effects of volumetric EOR and molecular and clinical factors on overall survival (OS) and progression-free survival by recursive partitioning analysis. The OS results were validated in two external cohorts (n = 365). Propensity score analysis of the combined cohorts (n = 757) was used to mimic a randomized clinical trial with varying levels of EOR. RESULTS: Recursive partitioning analysis identified three survival risk groups. Median OS was shortest in two subsets of patients with astrocytoma: those with postoperative tumor volume (TV) > 4.6 mL and those with preoperative TV > 43.1 mL and postoperative TV ≤ 4.6 mL. Intermediate OS was seen in patients with astrocytoma who had chemotherapy with preoperative TV ≤ 43.1 mL and postoperative TV ≤ 4.6 mL in addition to oligodendroglioma patients with either preoperative TV > 43.1 mL and residual TV ≤ 4.6 mL or postoperative residual volume > 4.6 mL. Longest OS was seen in astrocytoma patients with preoperative TV ≤ 43.1 mL and postoperative TV ≤ 4.6 mL who received no chemotherapy and oligodendroglioma patients with preoperative TV ≤ 43.1 mL and postoperative TV ≤ 4.6 mL. EOR ≥ 75% improved survival outcomes, as shown by propensity score analysis. CONCLUSION: Across both subtypes of LGG, EOR beginning at 75% improves OS while beginning at 80% improves progression-free survival. Nonetheless, maximal resection with preservation of neurological function remains the treatment goal. Our findings have implications for surgical strategies for LGGs, particularly oligodendroglioma. [Media: see text]

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.21.02929

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 175

Metadata

Authors
Hervey-Jumper, S. L., Zhang, Y., Phillips, J. J., Morshed, R. A., Young, J. S., McCoy, L., Lafontaine, M., Luks, T., Ammanuel, S., Kakaizada, S., Egladyous, A., Gogos, A., Villanueva-Meyer, J., Shai, A., Warrier, G., Rice, T., Crane, J., Wrensch, M., Wiencke, J. K., Daras, M., Oberheim Bush, N. A., Taylor, J. W., Butowski, N., Clarke, J., Chang, S., Chang, E., Aghi, M., Theodosopoulos, P., McDermott, M., Jakola, A. S., Kavouridis, V. K., Nawabi, N., Solheim, O., Smith, T., Berger, M. S., & Molinaro, A. M.
Venue
Journal of Clinical Oncology
Published
2023-04-10
Volume
41
Issue
11
Pages
2029-2042
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W4313544674
Cited by
175
References
6
FWCI
24.79
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma. https://app.cochat.ai/papers/10.1200/jco.21.02929
The paper
Hervey-Jumper, S. L., Zhang, Y., Phillips, J. J., Morshed, R. A., Young, J. S., McCoy, L., Lafontaine, M., Luks, T., Ammanuel, S., Kakaizada, S., Egladyous, A., Gogos, A., Villanueva-Meyer, J., Shai, A., Warrier, G., Rice, T., Crane, J., Wrensch, M., Wiencke, J. K., . . . Molinaro, A. M. (2023). Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma. Journal of Clinical Oncology. https://doi.org/10.1200/jco.21.02929

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.